Major changes:

• Addition of MenB (Bexsero to routine Schedule) and changes to MenB eligibility

• influenza programme 2023

• change to mRNA-CV (grey capped, no dilution 30 µg and 15/15µg)

• Throughout changed COVID-19 ‘booster’ dose to ‘first booster’ and ‘additional dose(s)’

• COVID-19 vaccination changed to 6 months after SARS-CoV-2 infection and previous dose for additional doses.

‍

A full summary can be found here.